Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Ultrasound ; 52(1): 78-85, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37915120

RESUMO

PURPOSE: Bacterial meningitis remains a global threat due to its high mortality. It is estimated that >1.2 million cases of bacterial meningitis are reported annually. Intracranial vasculopathy is an important, under-documented complication, easily detected by transcranial Doppler (TCD) ultrasonography. Following the PRISMA Guidelines, we reviewed the utility of TCD in bacterial meningitis. METHODS: This is a systematic review of observational studies on the use of TCD in patients with CSF-proven bacterial meningitis. Characteristic changes in TCD parameters along the course of the disease, correlation of TCD findings with neuroimaging, and functional outcomes were evaluated. RESULTS: Nine studies were included with a total of 492 participants (mean age of 42). The most common TCD finding was intracranial arterial stenosis of the MCA (50%-82%) and ischemia (33%) was the predominant neuroimaging finding. The presence of an abnormal TCD finding increased the risk of poor outcomes as high as 70%. CONCLUSIONS: Patients diagnosed with bacterial meningitis who underwent TCD show alterations in cerebral blood flow, correlating with imaging findings and poor outcomes. It aids in the diagnosis of its sequelae and can predict the prognosis of its outcome. TCD is a cost-effective, reliable modality for diagnosing vasculopathy associated with bacterial meningitis. It may prove useful in our armamentarium of management. Large prospective studies with long-term follow-up data may help establish the use of TCD in bacterial meningitis.


Assuntos
Meningites Bacterianas , Ultrassonografia Doppler Transcraniana , Humanos , Adulto , Ultrassonografia Doppler Transcraniana/métodos , Estudos Prospectivos , Meningites Bacterianas/complicações , Meningites Bacterianas/diagnóstico por imagem , Prognóstico , Velocidade do Fluxo Sanguíneo
2.
Cerebrovasc Dis Extra ; 14(1): 95-100, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39043151

RESUMO

INTRODUCTION: The Hub-and-Spoke stroke system seeks to enhance the efficiency of stroke care by establishing a cohesive network between healthcare facilities providing quality stroke care to patients. This study endeavors to evaluate the effectiveness and characterize the outcomes of acute ischemic stroke patients treated within the Hub-and-Spoke hospital system over 2 years. The assessment focused on thrombolysis rates, mortality, and disability at 3-month follow-up. METHODS: We conducted a retrospective single-center review to assess the service delivery and outcomes of acute ischemic stroke patients within the Hub-and-Spoke framework which was implemented in Q3 2021. The Hub-and-Spoke model aimed to provide appropriate neurological care for stroke patients, growing from four to eight spoke hospitals in 2 years. RESULTS: The study consisted of 132 stroke patients transferred to the hub hospital, and 42 (31.8%) of them had acute ischemic stroke. Among these 42 ischemic stroke patients, 76% of them were candidates for thrombolysis with a mean NIHSS of 12 (6-22). Among the subset of 32 patients eligible for intervention within the specified time window, a total of 23 individuals, constituting 72% received r-TPA. Regarding patients administered r-TPA, 91.2% demonstrated favorable functional outcomes with an mRS score of 0-1, while 8.7% exhibited a score of 2-3. Among those not given r-TPA, the mean NIHSS was 17 (ranging from 2 to 32). Their functional outcomes after 3 months revealed 52.5% with an mRS score of 0-1, 16% with a score of 2-3, 21.2% with a score of 4-5, and 10.5% with an mRS score of 6. CONCLUSION: Hub-and-Spoke networks represent a crucial advancement in stroke treatment, particularly for facilities lacking the capacity to manage strokes effectively. By leveraging added expertise and reducing the time from onset to diagnosis to treatment, these networks have significantly enhanced patient care. This enhancement is particularly evident in the increased rate of thrombolysis, resulting in reduced morbidity and prevention of mortality.


Assuntos
Avaliação da Deficiência , Fibrinolíticos , AVC Isquêmico , Terapia Trombolítica , Humanos , AVC Isquêmico/terapia , AVC Isquêmico/diagnóstico , AVC Isquêmico/mortalidade , Estudos Retrospectivos , Masculino , Filipinas/epidemiologia , Feminino , Idoso , Pessoa de Meia-Idade , Resultado do Tratamento , Fatores de Tempo , Fibrinolíticos/administração & dosagem , Prestação Integrada de Cuidados de Saúde , Estado Funcional , Recuperação de Função Fisiológica , Tempo para o Tratamento , Indicadores de Qualidade em Assistência à Saúde , Melhoria de Qualidade , Idoso de 80 Anos ou mais , Ativador de Plasminogênio Tecidual/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA